JP2009521707A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521707A5
JP2009521707A5 JP2008548837A JP2008548837A JP2009521707A5 JP 2009521707 A5 JP2009521707 A5 JP 2009521707A5 JP 2008548837 A JP2008548837 A JP 2008548837A JP 2008548837 A JP2008548837 A JP 2008548837A JP 2009521707 A5 JP2009521707 A5 JP 2009521707A5
Authority
JP
Japan
Prior art keywords
seq
sequence number
infected
detection
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008548837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/062632 external-priority patent/WO2007120362A2/en
Publication of JP2009521707A publication Critical patent/JP2009521707A/ja
Publication of JP2009521707A5 publication Critical patent/JP2009521707A5/ja
Pending legal-status Critical Current

Links

JP2008548837A 2005-12-27 2006-12-27 疾患のバイオマーカーとしての脂肪生成アデノウイルス Pending JP2009521707A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75340205P 2005-12-27 2005-12-27
PCT/US2006/062632 WO2007120362A2 (en) 2005-12-27 2006-12-27 Adipogenic adenoviruses as a biomarker for disease

Publications (2)

Publication Number Publication Date
JP2009521707A JP2009521707A (ja) 2009-06-04
JP2009521707A5 true JP2009521707A5 (https=) 2009-09-10

Family

ID=38610014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008548837A Pending JP2009521707A (ja) 2005-12-27 2006-12-27 疾患のバイオマーカーとしての脂肪生成アデノウイルス

Country Status (11)

Country Link
US (5) US7442511B2 (https=)
EP (2) EP1977009B1 (https=)
JP (1) JP2009521707A (https=)
KR (1) KR20080114683A (https=)
CN (1) CN101389768B (https=)
AU (1) AU2006342053A1 (https=)
BR (1) BRPI0620755A2 (https=)
CA (1) CA2635269A1 (https=)
MX (1) MX2008008453A (https=)
RU (1) RU2008130893A (https=)
WO (1) WO2007120362A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7507418B2 (en) * 2005-09-09 2009-03-24 Obetech, Llc Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes
US7442511B2 (en) * 2005-12-27 2008-10-28 Obetech, Llc Adipogenic adenoviruses as a biomarker for disease
US20120082659A1 (en) * 2007-10-02 2012-04-05 Hartmut Land Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
JP2009156254A (ja) * 2007-12-05 2009-07-16 Ibiden Co Ltd 排気ガス処理体の保持シール部材及び排気ガス処理装置
CN102015651B (zh) 2008-03-03 2014-12-31 Irm责任有限公司 作为tlr活性调节剂的化合物和组合物
WO2010011440A2 (en) * 2008-06-16 2010-01-28 Obetech Llc Diagnosis and treatment of lipogenic adenovirus infection associated with adipose tissue hypertrophy
JP5867952B2 (ja) 2009-06-10 2016-02-24 ノバルティス アーゲー ベンゾナフチリジン含有ワクチン
WO2011027222A2 (en) 2009-09-02 2011-03-10 Novartis Ag Immunogenic compositions including tlr activity modulators
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
WO2011050299A2 (en) * 2009-10-22 2011-04-28 Obetech Llc Adenovirus infection in animals
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
US8591412B2 (en) * 2009-11-18 2013-11-26 Nohands, Llc Method and system for preventing virus-related obesity and obesity related diseases
BR112012014624A8 (pt) 2009-12-15 2017-12-26 Novartis Ag suspensão homogênea de compostos de imunopotenciação e usos dos destes
EA031379B1 (ru) 2010-03-23 2018-12-28 Новартис Аг Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
WO2011119915A2 (en) * 2010-03-25 2011-09-29 Obetech Llc Method for detecting lipogenic adenovirus
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
US8951980B2 (en) * 2010-07-08 2015-02-10 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Adenovirus Ad36 E4 orf1 protein for prevention and treatment of non-alcoholic fatty liver disease
WO2012006550A2 (en) * 2010-07-09 2012-01-12 Obetech Llc Methods and compositions for treatment of lipogenic virus related conditions
US9254320B2 (en) 2010-12-17 2016-02-09 Globeimmune, Inc. Compositions and methods for the treatment or prevention of human adenovirus-36 infection
BR112015018014A2 (pt) 2013-02-01 2017-07-11 Glaxosmithkline Biologicals Sa liberação intradérmica de composições imunológicas compreendendo agonistas do receptor do tipo toll
US9925254B2 (en) 2014-11-05 2018-03-27 The United States Of America As Represented By The Secretary Of The Navy Synthetic antigen constructs against Campylobacter jejuni
JP7362667B2 (ja) 2018-02-12 2023-10-17 イニミューン・コーポレーション Toll様受容体リガンド
AU2019352906B2 (en) * 2018-10-05 2026-01-22 Minomic International Ltd. Biomarker combinations for determining aggressive prostate cancer
JP2023547677A (ja) 2020-11-04 2023-11-13 エリゴ・バイオサイエンス キューティバクテリウム・アクネス組換えファージ、その産生方法及び使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692152B2 (en) * 1993-03-17 1998-06-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
AU6884298A (en) * 1997-04-04 1998-10-30 Obetech, Llc Viral obesity methods and compositions
JP2000072800A (ja) * 1998-08-26 2000-03-07 Toagosei Co Ltd 抗アデノウイルス37型モノクローナル抗体及びその用途
CA2632013C (en) * 2005-11-30 2013-02-26 Wayne State University Adenovirus 36 e4 orf 1 gene and protein and their uses
US7442511B2 (en) * 2005-12-27 2008-10-28 Obetech, Llc Adipogenic adenoviruses as a biomarker for disease

Similar Documents

Publication Publication Date Title
JP2009521707A5 (https=)
JP6542797B2 (ja) 標的の増幅およびマイクロアレイ検出を集積したマイクロ流体装置
WO2009061783A3 (en) Dna microarray having hairpin probes tethered to nanostructured metal surface
JP2008532485A5 (https=)
JP2010029220A5 (https=)
Toriello et al. Multichannel reverse transcription-polymerase chain reaction microdevice for rapid gene expression and biomarker analysis
EP2021516A4 (en) NUCLEIC ACID PRIMERS AND PROBES FOR THE DETECTION OF INFLUENZA VIRUSES OF PEOPLE AND BIRDS
JP2007534308A5 (https=)
DE60016947D1 (de) Template abhängige ligierung mit pna-dna chimerischen sonden
JP2015156872A5 (https=)
WO2001012852A3 (en) Polymerase extension at 3' terminus of pna-dna chimera
WO2007041342A3 (en) Labeled nucleotide analogs and uses therefor
JP2017519774A5 (https=)
WO2008001376A3 (en) Detection of analytes in a medium
RU2019137083A (ru) Линкеры в виде короткой боковой ручки для нуклеотидов в областях применения секвенирования
JP2005530695A5 (https=)
WO2019073049A1 (en) ISOTHERMIC AMPLIFICATION IN SOLID PHASE
JP2012519003A5 (https=)
JP2014083052A5 (https=)
CN1548545A (zh) 一种用于多靶序列pcr检测的公共引物及其对多靶核酸序列进行pcr扩增的方法
CN106498077B (zh) Dna扩增产物快速检测方法
WO2006116303A3 (en) Fluorescent multiplex hpv pcr assays
MD3300F1 (en) Oligonucleotide primer for hepatitis C virus RNA detection
CY1113242T1 (el) Μεθοδος και μεσα για ανιχνευση ανθρωπινων ιων θηλωματος
Nourinejhad Zarghani et al. Genetic diversity of and selection pressure on grapevine fanleaf virus movement protein in Iranian isolates